Quarterly portfolio review prep

Good instinct on compliance. Without your books, policies, or prior meeting notes I will stay high level:

• Performance versus goals and anything material since last quarter.
• Concentration, liquidity, and risk versus the profile they agreed to.
• Cash needs, tax items, and any product or regulatory updates worth verbalizing.

Share rough weights or policy names if you want house-style language. Want a generic opening line for the meeting, or a compliance "do not say" reminder list?

Here's a concise snapshot:

• GitHub: 3 open PRs on release/acme-launch; the API rate-limit change is still in review.
• Notion: Product brief is marked "Ready for review"; decision log notes pricing approval is pending.
• Google Workspace: Next calendar block with stakeholders is tomorrow 10:00 AM; the shared prep doc was updated this morning.

I can refresh these sources before the meeting, draft the stakeholder follow-up, or break this into owners and next steps -- what should I run first?

Lead with performance versus their stated goals in plain language, then name the biggest driver of change since last quarter. Be extra careful anywhere you discuss alternatives or illiquid strategies: stick to approved disclosures, confirm risk tolerance still matches, and do not improvise fee or return language. Without their actual allocation I cannot tell you which sleeve needs the soft touch.

Open with YTD +4.2% versus benchmark, then be direct that international equity is about six points over policy, that is your main tracking-error story for the quarter. They already asked about alts fees on slide 5 from the August letter, so expect that thread to return. On alts, stay on disclosure pack v3, confirm accredited status before any product detail (it is on file, still say it once in the room). If you want one sentence for the risky bit: "We are overweight international versus your policy; we can discuss trimming or keeping the tilt and what that means for risk."

I don't have access to your tools, so I can't see live status.

Sample household quarterly: portfolio model, last touchpoints, and disclosure pack line up like this:

• Portfolio: Model shows YTD +4.2% vs benchmark; international equity sits about six points above policy target; primary tracking-error flag.
• Google Workspace: Last quarterly letter went out Aug 12; client asked about the fee schedule on alts; note captured on deck slide 5.
• Compliance: Alts will come up; stay on disclosure pack v3, confirm accredited-investor status before product detail (file shows accredited; still verbalize once in meeting).

I can draft a compliant alts talking-points strip, sketch a what-if rebalance toward policy, or prep meeting notes for the file after. Which one?

Lead with performance versus their stated goals in plain language, then name the biggest driver of change since last quarter. Be extra careful anywhere you discuss alternatives or illiquid strategies: stick to approved disclosures, confirm risk tolerance still matches, and do not improvise fee or return language. Without their actual allocation I cannot tell you which sleeve needs the soft touch.

Open with YTD +4.2% versus benchmark, then be direct that international equity is about six points over policy, that is your main tracking-error story for the quarter. They already asked about alts fees on slide 5 from the August letter, so expect that thread to return. On alts, stay on disclosure pack v3, confirm accredited status before any product detail (it is on file, still say it once in the room). If you want one sentence for the risky bit: "We are overweight international versus your policy; we can discuss trimming or keeping the tilt and what that means for risk."